ISYNA1
Inositol-3-phosphate synthase 1
Also known as: Ino1, INO1_HUMAN, INOS, IPS
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NPH2
- Gene
- ISYNA1
- Ensembl
- ENSG00000105655
- Chromosome
- 19
- Canonical length
- 558 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes an inositol-3-phosphate synthase enzyme. The encoded protein plays a critical role in the myo-inositol biosynthesis pathway by catalyzing the rate-limiting conversion of glucose 6-phosphate to myoinositol 1-phosphate. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the short arm of chromosome 4. [provided by RefSeq, Nov 2011]
Canonical amino-acid sequenceUniProt
558 residues, UniProt reviewed canonical sequence.
>Q9NPH2|ISYNA1
1 MEAAAQFFVE SPDVVYGPEA IEAQYEYRTT RVSREGGVLK VHPTSTRFTF RTARQVPRLG
61 VMLVGWGGNN GSTLTAAVLA NRLRLSWPTR SGRKEANYYG SLTQAGTVSL GLDAEGQEVF
121 VPFSAVLPMV APNDLVFDGW DISSLNLAEA MRRAKVLDWG LQEQLWPHME ALRPRPSVYI
181 PEFIAANQSA RADNLIPGSR AQQLEQIRRD IRDFRSSAGL DKVIVLWTAN TERFCEVIPG
241 LNDTAENLLR TIELGLEVSP STLFAVASIL EGCAFLNGSP QNTLVPGALE LAWQHRVFVG
301 GDDFKSGQTK VKSVLVDFLI GSGLKTMSIV SYNHLGNNDG ENLSAPLQFR SKEVSKSNVV
361 DDMVQSNPVL YTPGEEPDHC VVIKYVPYVG DSKRALDEYT SELMLGGTNT LVLHNTCEDS
421 LLAAPIMLDL ALLTELCQRV SFCTDMDPEP QTFHPVLSLL SFLFKAPLVP PGSPVVNALF
481 RQRSCIENIL RACVGLPPQN HMLLEHKMER PGPSLKRVGP VAATYPMLNK KGPVPAATNG
541 CTGDANGHLQ EEPPMPTTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ISYNA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 220 nTPM
Expression across tissuesHPA
Tissue
- testis: 220 nTPM
- choroid plexus: 200 nTPM
- kidney: 126 nTPM
- ovary: 94 nTPM
- blood vessel: 81 nTPM
- fallopian tube: 77 nTPM
Single-cell type
- cytotrophoblasts: 1,352 nCPM
- syncytiotrophoblasts: 1,149 nCPM
- migrating cytotrophoblasts: 793 nCPM
- granulosa cells: 649 nCPM
- late spermatids: 382 nCPM
- fallopian secretory cells: 345 nCPM
Immune cell
- NK-cell: 15 nTPM
- naive CD8 T-cell: 9 nTPM
- memory CD4 T-cell: 8.2 nTPM
- gdT-cell: 8.1 nTPM
- memory CD8 T-cell: 6.9 nTPM
- MAIT T-cell: 6.2 nTPM
Brain region
- choroid plexus: 466 nTPM
- hypothalamus: 42 nTPM
- hippocampal formation: 30 nTPM
- thalamus: 30 nTPM
- midbrain: 29 nTPM
- medulla oblongata: 26 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.27
- DepMap mean gene effect
- -0.26
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- inositol-3-phosphate synthase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- NAD(P)-binding domain superfamily
- Myo-inositol-1-phosphate synthase
- Myo-inositol-1-phosphate synthase, GAPDH-like
- Myo-inositol-1-phosphate synthase
- Myo-inositol-1-phosphate synthase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ISYNA1 as an antibody target. Whether an autoantibody or antibody against ISYNA1 could matter depends on whether native ISYNA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ISYNA1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ISYNA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...